Teva to Host Conference Call on February 24, 2025 to Discuss New Data Presented for Duvakitug (anti-TL1A) Positive Phase 2b results at the 20th Annual Congress of the European Crohn's and Colitis Organisation (ECCO) 19-02-2025, 04:30

Mattermost announces “Mattermost for Microsoft Teams” to 10-03-2023, 00:01

Axi Select Traders Share Their Experience So Far on Axi’s Capital Allocation Program in New Podcast Series Axi Select Talks 8-08-2024, 18:00